IRRAS
Share:
Subscribe:
news.cision.com
/
IRRAS
/
IRRAS strengthens position in neurocritical care by acquiring proprietary assets, including four US FDA-cleared products
/
Irras
Irras
Tue, May 07, 2019 08:00 CET
Low resolution
Medium resolution
Original resolution
Subscribe
